稳定敲除CACYBP/SIP基因的MCF-7细胞株的构建及其细胞增殖的变化  被引量:2

MCF-7 cell strain with CACYBP/SIP gene stabilized knockout and its proliferation

在线阅读下载全文

作  者:王会峰 赵志军 王燕 吴媛媛 王宁菊 WANG Hui-feng;ZHAO Zhi-jun;WANG Yan;WU Yuan-yuan;WANG Ning-ju(General Hospital of Ningxia Medical UniversityDepartment of Oncology,Cancer Hospital,Yinchuan 750004,China;Department of Medical laboratory Center,Yinchuan 750004,China)

机构地区:[1]宁夏医科大学总医院肿瘤医院肿瘤内科,宁夏银川750004 [2]宁夏医科大学总医院医学实验中心,宁夏银川750004

出  处:《基础医学与临床》2019年第12期1682-1688,共7页Basic and Clinical Medicine

基  金:国家自然科学基金(81460400)

摘  要:目的利用CRISPR/Cas9系统构建CACYBP-/-乳腺癌MCF-7基因缺陷细胞株,并研究该基因敲除株对细胞增殖能力的影响。方法设计特异sgRNA序列,构建Lenti-CAS9-sgRNA-puro质粒,转染MCF-7细胞,puromycin抗性筛选,Cruiser检测sgRNA活性,极限稀释法筛选单克隆株,Western blot检测CACYBP/SIP蛋白的表达,Brdu和MTT试剂盒检测CACYBP/SIP缺失后细胞增殖能力。结果成功构建Lenti-CAS9-sgRNA-puro质粒,puromycin最佳筛选浓度为0.9μg/mL,sgRNA1活性最高,获得的单克隆系测序唯一敲除CACYBP/SIP的MCF-7细胞株增殖能力减弱(P<0.05)。结论敲除CACYBP/SIP的MCF-7细胞株增殖能力减弱。Objective To construct the CACYBP/SIP-/-MCF-7 cell strain and study the changes of its pro-liferation.Methods The specific sgRNA sequence was designed and Lenti-CAS9-sgRNA-puro plasmid was constructed,MCF-7 cells were transfected with the plasmid,and puromycin resistance was used to screen for positive clone.Cruiser was used to detect sgRNA activity,monoclonal strain was screened by limiting dilution method,and CACYBP/SIP protein expression was detected by Western blot,Brdu and MTT kits were used to detect cell proliferation after CACYBP/SIP gene deletion.Results A Lenti-CAS9-sgRNA-puro plasmid was successfully cons-tructed.The optimal screening concentration of puromycin was 0.9μg/mL.The results of Cruiser assay showed that sgRNA1 activity was the highest,and the obtained monoclonal strain was sequenced only.MTT and Brdu results showed that the proliferation of CACYBP/SIP-/-MCF-7 cell line was weakened(P<0.05).Conclusions CACYBP/SIP-/-MCF-7 cell strain is successfully obtained and it’s proliferation ability is decreased.

关 键 词:CRISPR/Cas9系统 CACYBP/SIP MCF-7细胞 

分 类 号:R73-37[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象